PharmExec Direct | From the editors of Pharmaceutical Executive
Send Us Some Feedback
 
September 10 , 2009 | ISSUE NUMBER 115 VOL 6

Legal
Sepracor Faces Shareholder Lawsuit in Wake of $2.6B Deal
Some shareholders think they were shafted in the multi-billion dollar deal between Sepracor and Dainippon Sumitomo Pharma. They’re so miffed, in fact, that they’ve filed a lawsuit stating that the amount offered undervalues the company and its shares.

People
Roche Shifts Execs in Anticipation of Departures
With the pending retirement of three senior-level executives, Roche announced a new corporate executive team to bridge the personnel gap while the company looks for new leaders.

Technology
Hot Topics in Supply Chain Management
Times are changing in the pharmaceutical and life sciences sectors, and the supply chains have to adapt to a new set of challenges, says Kenneth Porter of specialist consultancy Total Logistics.

Global
UK Pharmacies Dealing with Drug Shortages
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?


Advertisement:
PharmaForce 2009
The Premier North American Pharmaceutical Sales Force Effectiveness Conference
October 5-7, Hilton City Avenue, Philadelphia
www.pharmaforceus.com

Take home tried and tested strategies to increase pharmaceutical sales force efficiency by attending PharmaForce 2009, and meet with more than 200 of the best sales strategists in the business.

To register with a 25% discount call 1.888.482.6012 with code 10406.004XA075, or register online at www.pharmaforceus.com


Amylin Pharmaceuticals elected Paulo F. Costa as chairman of the board // Orexigen Therapeutics hired Mark Booth as chief commercial officer // McCann Healthcare Worldwide appointed Charlie Buckwell to worldwide head of medical communications // Torre Lazur Healthcare Group promoted Jennifer Mulvaney to executive vice president, executive creative director/integration and Marcia Goddard to executive vice president, creative director for Torre Lazur McCann // HC&B Healthcare Communications hired Jessica Worrell as art director // MicroMass Communications joined Worldwide Partners, Inc. (WPI) to increase its global outreach // Adamas Pharmaceuticals named Michael D. Coffee, senior vice president, sales and marketing, and Amy K. Patick, vice president, research // Inc. Magazine recognized TGaS Advisors as one of the fastest-growing private companies in the US in its 2009 rankings // MBS/Vox, the research-based consultancy unit of CommonHealth, hired David Curry as a senior analyst and Julie Hoops as an analyst // François Mandeville joins Strand Life Sciences management team //


Webcasts

September 10 An Evolving Standard for Success: Proving Product Value Through Comparative Effectiveness Data
Wednesday, September 10 at 11 AM EDT

September 14 Develop Competitive Advantage Through Business Analytics in the New Pharmaceutical Commercial Model
Wednesday, September 23, 2009 at 11:00 AM EDT

September 23 Mining Business and Technology Best Practices: Winning Strategies for the E-Commerce Space
Wednesday, September 14 at 11 AM EDT

September 24 Drugs, Devices or Data – Which is Most Valuable? An Expert Panel Debates
Thursday, September 24, 2009 at 2:00 PM EDT

September 14–15 4th Annual Forum on Educational Grants for the Bio/Pharmaceutical Industry, Philadelphia, PA

September 21–24 5th Annual Process Excellence Week for the Service & Transactional World, Chicago, IL

September 30 Prix Galien 2009 Awards Ceremony, New York, NY

October 5–7 BioNetwork 2009: The 7th Annual Pharmaceutical-Biotech Partnering Conference, Laguna Niguel, California

October 20–21 CBI’s Leadership Summit on Global Interactions with Healthcare Providers, Arlington, VA




 
  FindPharma  
  Search  

Survey
Are you seeking to build a defined strategic capability to communicate and engage in this emerging area of cyberspace?
Click To Vote
Quick Links

Middlebrook Pharma Cuts 100 Jobs

Acadia Pharma Shares Crash After Lead Parkinson’s Drug Fails in Trial

Sagent Pharmaceuticals Announces Launch of Adenosine Injection

Scolr Pharma Names Third CEO In A Year


Follow Pharm Exec on Twitter



Click Here



Click Here

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to Pharm Exec Direct.. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive Visit the PharmExec website